Research and development
Research and Development at Héma-Québec: An Overview
Research and development (R&D) activities must be an important focus of any organization operating in the health care field, where technological advances are steady and rapid. At Héma-Québec, the efforts dedicated to R&D activities support overall business operations. These activities are in line with the major orientations of Héma-Québec’s 2012–2015 strategic plan. The R&D Division plays a key role in improving quality and efficiency, and acts as an essential innovation driver.
Over the next few years, Héma-Quebec plans to expand its biological product offering. The R&D Division is involved in the development, from the earliest stages, of these new product lines. Blood and its derivatives, as well as cord blood, remain core components of Héma-Québec’s mission. The line of available human tissue products is expanding and diversifying. Cellular production, which aims at providing hospital clients with a completely new range of products for which our organization is poised to become a key player, is mobilizing substantial R&D efforts.
The R&D Division also fosters the growth of an economic environment that is favourable to innovation through networking and collaboration with local, national and international partners in academic and industrial sectors of the life sciences. This ecosystem, which brings together various organizations that share an interest in biomedical research, provides additional opportunities for innovation and new product development.
All R&D activities are evaluated by two advisory committees:
- the Cellular and Tissular ProductionAdvisory Committee
- the Scientific and Medical Advisory Committee
A third committee, the Research Ethics Committee, is the ultimate authority in matters of compliance with research ethics standards.